T Lauritzen
Overview
Explore the profile of T Lauritzen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
133
Citations
1909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bo A, Thomsen R, Nielsen J, Nicolaisen S, Beck-Nielsen H, Rungby J, et al.
Diabetes Metab Res Rev
. 2017 Nov;
34(3).
PMID: 29172021
Aim: To examine the association between early onset of type 2 diabetes mellitus (DM) and clinical and behavioural risk factors for later complications of diabetes. Methods: We conducted a cross-sectional...
2.
Kalra S, Lauritzen T, Sharmanov T, Akanov Z, Al Awadi F, Das A, et al.
Diabet Med
. 2017 May;
34(8):1169-1170.
PMID: 28477409
No abstract available.
3.
Webb D, Zaccardi F, Davies M, Griffin S, Wareham N, Simmons R, et al.
Diabetes Metab Res Rev
. 2016 Dec;
33(4).
PMID: 28029211
Background: It is unclear whether cardiovascular risk factor modification influences the development of renal disease in people with type 2 diabetes identified through screening. We determined predictors of albuminuria 5 ...
4.
Jensen T, Vistisen D, Fleming T, Nawroth P, Rossing P, Jorgensen M, et al.
Diabet Med
. 2016 Aug;
33(12):1625-1631.
PMID: 27504739
Aims: The glycolysis-derived metabolite methylglyoxal has been linked to clinical microvascular complications, including diabetic nephropathy. We aimed to further investigate the hypothesis that methylglyoxal is involved in decline in renal...
5.
Hoffmann-Petersen N, Lauritzen T, Bech J, Pedersen E
J Hum Hypertens
. 2016 Jun;
31(2):93-98.
PMID: 27334521
Telemonitoring of home blood pressure measurements (TBPM) is a new and promising supplement to diagnosis, control and treatment of hypertension. We wanted to compare the outcome of antihypertensive treatment based...
6.
Eliraqi G, Vistisen D, Lauritzen T, Sandbaek A, Jorgensen M, Faerch K
Diabet Med
. 2015 Mar;
32(8):1085-9.
PMID: 25819139
Aim: To investigate whether intensive multifactorial treatment can reverse the predisposed adverse phenotype of people with Type 2 diabetes who have a family history of diabetes. Methods: Data from the...
7.
Hansen C, Jensen T, Jensen J, Nawroth P, Fleming T, Witte D, et al.
Diabet Med
. 2015 Mar;
32(6):778-85.
PMID: 25761542
Aims: Cardiovascular autonomic neuropathy and diabetic peripheral neuropathy are common diabetic complications and independent predictors of cardiovascular disease. The glucose metabolite methylglyoxal has been suggested to play a causal role...
8.
Tao L, Wilson E, Wareham N, Sandbaek A, Rutten G, Lauritzen T, et al.
Diabet Med
. 2015 Feb;
32(7):907-19.
PMID: 25661661
Aims: To examine the short- and long-term cost-effectiveness of intensive multifactorial treatment compared with routine care among people with screen-detected Type 2 diabetes. Methods: Cost-utility analysis in ADDITION-UK, a cluster-randomized...
9.
Simmons R, Carlsen A, Griffin S, Charles M, Christiansen J, Borch-Johnsen K, et al.
Diabet Med
. 2014 Sep;
31(12):1577-85.
PMID: 25185778
Aims: To examine variation between general practices in the prescription of lipid-lowering treatment to people with screen-detected Type 2 diabetes, and associations with practice and participant characteristics and risk of...
10.
Janukonyte J, Parkner T, Lauritzen T, Christiansen J, Frystyk J, Pedersen H, et al.
Growth Horm IGF Res
. 2014 Jul;
24(5):198-204.
PMID: 25037883
Background: Diurnal variation in serum growth hormone (s-GH) levels after exogenous GH delivery has previously been reported in patients with no endogenous GH secretion. Changes in postural position or physical...